Review Article
The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis
Table 2
Main meta-analysis and subgroup analyses of diagnostic odds ratio.
| | Analysis | Studies | Pooled DOR (CI 95) | I2 (%) |
| | Main analysis | 18 | 13.05 (8.88–19.19) | 100.0 | | By country | | (i) China | 6 | 10.12 (6.78–15.11) | 95.6 | | (ii) South Korea | 2 | 18.50 (14.07–24.34) | 85.3 | | (iii) Turkey | 2 | 14.94 (3.20–69.60) | 82.5 |
| | By criteria | | (i) IDF | 8 | 10.39 (5.16–20.92) | 98.8 | | (ii) ATP-III | 5 | 15.24 (9.37–24.80) | 82.0 | | (iii) JIS | 3 | 12.23 (5.40–27.68) | 94.1 |
| | By gender | | (i) Female-only | 9 | 14.28 (8.74–23.35) | 95.5 | | (ii) Male-only | 6 | 12.15 (9.08–16.26) | 81.9 |
|
|
IDF: International Diabetes Federation; ATP-III: adult treatment panel III; JIS: joint interim statement; and DOR: diagnostic odds ratio. Significantly different between subgroups. |
